EUVIMED · CrossrefJournal
Clinical Colorectal Cancer
ISSN 1533-0028 · Elsevier BV
Latest articles
Real-world use of encorafenib plus cetuximab after prior systemic therapy in patients with BRAFV600E-mutant metastatic colorectal cancer: a pooled analysis of European observational studies
Prognostic significance of subclassifying clinical T3 category in rectal cancer: a Dutch nationwide cohort with standardised MRI re-assessment
Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon
Diagnostic and Treatment Intervals for Colorectal Cancer and Associations With Overall Survival and Disease Stage: An Australian Data Linkage Study
A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131
EGFR Targeting With Afatinib and Cetuximab Versus Cetuximab Alone in Chemorefractory Wild-type RAS Metastatic Colorectal Cancer: A Randomized Phase II Study With Circulating Tumor Cell Analysis
Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study
Successful Encorafenib and Cetuximab Re-Challenge Combined With Nivolumab in BRAF V600E Mutated, Mismatch-Repair-Proficient Metastatic Colorectal Cancer – A Case Report From the AGMT mCRC Registry
Circulating Tumor DNA as a Biomarker for Recurrence After Curative Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Meta-Analysis
Spontaneous Regression of Colon Adenocarcinoma: A Case for Reconsideration
Effects of Cancer Treatment on Inflammation in Colorectal Cancer Patients: A Longitudinal Study
Editorial Board
Table of contents
Impact of distal resection margin on survival after tumour-specific mesorectal excision for rectal cancer: retrospective cohort study
Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
Restoring Immune Mediated Disease Control by Ipilimumab Re-exposition in a Heavily pretreated Patient With MSI-H mCRC
Correlative Significance of Tumor Regression Grade and ypT Category in Patients Undergoing Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
QUAD SHOT Radiotherapy and Doublet Immunotherapy in the Management of Anal Mucosal Melanoma: A Case Series of Efficacy and Toxicity of a Novel Treatment Approach and a Review of the Literature
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer
Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer
Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy
Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer
Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review
MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer
Epidemiology and Outcomes of Patients With Brain Metastases From Colorectal Cancer—Who Are These Patients?
Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer
Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial
EUVIMED